Jean Jingrong Cui - Director, Turning Point Therapeutics, Inc

As of June 10, 2020


Jean Jingrong Cui Net Worth

  • Net worth is estimated to be at least $101.56M
  • Owns at least 840,383 units of Turning Point Therapeutics, Inc stock
  • Sold an estimated value of $40.48M in the last year at Turning Point Therapeutics, Inc

Jean Jingrong Cui Compensation at Turning Point Therapeutics, Inc in 2020

  • Earned a $43,217 salary
  • Received a total compensation of $3,102,434

Jean Jingrong Cui Trading

  • Largest sale of shares was 118,500 units , worth over $6.13M on December 9, 2019
  • In total has made about 23 transactions over a year
  • Usually trades in January, December and February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jean Jingrong Cui Mailing Address

  • Mailing address is C/o Turning Point Therapeutics, Inc. 10628 Science Center Dr., Ste. 225 San Diego CA 92121 CA

Turning Point Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Athena Countouriotis, M.D. 2020 $580,000 - - $14,131,423 $539,400 $11,400 $15,262,223
Athena Countouriotis, M.D. 2018 $329,442 $400,000 $ $7,766,667 $158,971 $8,690 $8,663,770
Yi Larson 2020 $451,688 - - $1,434,883 $255,600 $114,716 $2,256,887
Yi Larson 2019 $158,523 $360,757 - $11,715,012 $283,500 $61,633 $12,579,425
Annette North 2020 $400,000 - - $2,434,953 $230,400 $11,400 $3,076,753
Annette North 2018 $ $ $ $ $ $ $
Andrew Partridge 2020 $220,758 - $1,288,710 $5,210,033 $304,560 $202,500 $7,226,561
Andrew Partridge 2018 $ $ $ $ $ $ $
Siegfried Reich, Ph.D. 2020 $325,000 - - $5,227,485 $187,097 - $5,739,582
Siegfried Reich, Ph.D. 2018 $ $ $ $ $ $ $
Jingrong Jean Cui, Ph.D. 2020 $43,217 - - $1,870,156 - $1,189,061 $3,102,434
Jingrong Jean Cui, Ph.D. 2018 $399,289 $ $ $11,715,012 $283,500 $3,674 $12,401,475
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1595893/000119312521117723/d27986ddef14a.htm

Turning Point Therapeutics, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on August 31, 2021 by Annette North worth over $800K
  • In the last 2 years, insiders at Turning Point Therapeutics, Inc sold an estimated value of $71.63M and bought an estimated value of $66.53M
  • The most active traders are Jean Jingrong Cui, Director,  Annette North, EVP,  and Athena Countouriotis, President & CEO
  • Insider trading is most common in June, with the busiest year in 2020

Turning Point Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1